Temperature induces significant changes in both glycolytic reserve and mitochondrial spare respiratory capacity in colorectal cancer cell lines
/in Colorectal Cancer, Hyperthermia, International PublicationsDynamic and specific immune responses against multiple tumor antigens were elicited in patients with hepatocellular carcinoma after cell-based immunotherapy
/in Dendritic Cells, Hepatocellular Carcinoma, International PublicationsCurrent status of clinical trials assessing oncolytic virus therapy for urological cancers
/in Hypernephroma, International Publications, Newcastle Disease Virus, Prostate Cancer, Urothelial CarcinomaOptimizing non-invasive radiofrequency hyperthermia treatment for improving drug delivery in 4T1 mouse breast cancer model
/in Breast Cancer, Hyperthermia, International PublicationsImmune and viral therapies for malignant primary brain tumors
/in Dendritic Cells, Glioblastoma, International Publications, Newcastle Disease VirusA comprehensive review of immunotherapies in prostate cancer
/in Dendritic Cells, International Publications, Newcastle Disease Virus, Prostate CancerImmunomonitoring reveals interruption of anergy after vaccination in a case of type-2-papillary renal cell carcinoma
/in Dendritic Cells, Hypernephroma, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer